Abstract:Introduction Cardiomyopathy causes ∼12.1% of pregnancy-related maternal mortality. Dilated cardiomyopathy(DCMP) in pregnancy is often either already known or discovered in the 2nd trimester as hemodynamic changes begin. Management is challenging as guideline directed medical therapy for heart failure with reduced ejection fraction is contraindicated in pregnancy. Antepartum cardiogenic shock(reported incidence ∼17%) significantly worsens outcomes. We describe using an Impella 5.5 micro-axial pump to successfully support a pregnancy complicated by DCMP and cardiogenic shock(CS). Clinical Case A 27-year-old gravida 3, parity 2 presented with CS in week 24 of pregnancy. Symptoms manifested around week 16 and progressively worsened. She was orthopneic and had anasarca. Lactic acid at presentation was 7.5mmol/L. Labs were otherwise unremarkable. Right heart catheterization revealed RA pressure of 15mmHg, PA pressure of 64/36mmHg (mean 45mmHg), cardiac index of 1.6L/min/m2 and systemic vascular resistance >1300 dyne/cm5. PCWP could not be measured due to severe PA dilation. Echocardiogram revealed biventricular dilation with an LVEF<20%, LVEDd 7.8cm & severe mitral regurgitation. She was initiated on dobutamine but transitioned to milrinone for more effective vasodilation. She received aggressive diuresis. Anasarca improved but elevated PA pressures persisted. Fetal monitoring was performed by the maternal-fetal medicine/obstetric team. Due to her critical condition and body habitus, assessing fetal growth accurately was challenging although there was restricted growth at baseline. Cardiac index improved modestly and a decision was made to escalate support to an axillary Impella 5.5 to augment flow to the mother and, hopefully, placental flow to the fetus. She underwent a successful cesarean delivery 4 weeks after Impella placement. The Impella remained for 3 weeks post-partum hoping for ventricular recovery. Hope unrealized, she underwent an HM3 LVAD placement. Cardiac biopsy at that time showed disarrayed hypertrophic cardiomyocytes without interstitial fibrosis or infarction. She remains independent and functional at follow-up. Her daughter is home after 3 months in the NICU. Discussion Impella is a percutaneous LVAD used to support patients with CS. Its use in pregnancy is rare and safety data in this population is limited. Pregnancy in patients with DCMP is potentially dangerous given the increased demands on the cardiovascular system. Treating CS in pregnancy is complex and requires a multidisciplinary approach. Conventionally, options were early delivery or termination. There have been few case reports describing Impella use in pregnancy with CS. To our knowledge this is the first reported case using an axillary Impella 5.5 to support a patient for several weeks to achieve cardiac stability as well as allow fetal maturity. The axillary placement of the Impella 5.5 also helped the patient maintain ambulation. Using an Impella in pregnancy requires careful consideration of potential risks and benefits for mother and fetus, and close monitoring by a multidisciplinary team.

The effect of surgical operation on growth hormone levels in plasma.

One Pump For Two Hearts - A Single-center Experience With An Impella 5.5 Micro-axial Pump In A Peripartum Patient With Cardiogenic Shock

One Pump for Two Hearts: Using an Impella 5.5 Micro-Axial Pump in Peripartum Cardiogenic Shock

Ontogenetic trends in the morphological features of main stem annual shoots of Pinus pinaster (Pinaceae).

Successful Pregnancy After Left Ventricular Assist Device Explantation for Myocardial Recovery

Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals

A Practical Approach to the Diagnosis and Initial Management of Acute Right Ventricular Failure during Pregnancy using Point-of-Care Ultrasound

Cardiogenic Shock and Utilization of Mechanical Circulatory Support in Pregnancy

Pregnancy in women with a Fontan circulation: Short and long-term outcomes

Pregnancy in Patients with the Fontan Operation

Peripartum anesthetic management in patients with left ventricular noncompaction: a case series and review of the literature

Successful multimodality management of severe pulmonary arterial hypertension during pregnancy with VA-ECMO and atrial septostomy using stent

Assessing The Outcomes In Black Women Patients Following Left Ventricular Assist Device Implantation: Representation Through A Single Center Analysis

Evolution of Mechanical Circulatory Support for advanced heart failure

Pulmonary arterial hypertension in pregnancy

Common clonal origin of lymphocytes and plasma cells in splenic lymphoma with villous lymphocytes

Left Ventricular Assist Device in Advanced Refractory Heart Failure: A Comprehensive Review of Patient Selection, Surgical Approaches, Complications and Future Perspectives

Creating a Multidisciplinary Pregnancy Heart Team

Pregnancy in women with congenital heart disease: a focus on management and preventing the risk of complications

Outcome of pregnancy in women with unrepaired atrial septal defect - study of a single tertiary centre

Left ventricular assist devices: A historical perspective at the intersection of medicine and engineering